Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts.

de Lange SV, Bakker MF, Monninkhof EM, Peeters PHM, de Koekkoek-Doll PK, Mann RM, Rutten MJCM, Bisschops RHC, Veltman J, Duvivier KM, Lobbes MBI, de Koning HJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, van Gils CH.

Clin Radiol. 2018 May 11. pii: S0009-9260(18)30157-0. doi: 10.1016/j.crad.2018.04.002. [Epub ahead of print]

PMID:
29759590
2.

The combined effect of mammographic texture and density on breast cancer risk: a cohort study.

Wanders JOP, van Gils CH, Karssemeijer N, Holland K, Kallenberg M, Peeters PHM, Nielsen M, Lillholm M.

Breast Cancer Res. 2018 May 2;20(1):36. doi: 10.1186/s13058-018-0961-7.

3.

Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.

Cairat M, Fournier A, Murphy N, Biessy C, Scalbert A, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Arveux P, Boutron-Ruault MC, Cadeau C, Fortner RT, Kaaks R, Boeing H, Aleksandrova K, Peeters PHM, Van Gils CH, Wareham NJ, Khaw KT, Aune D, Riboli E, Gunter MJ, Dossus L.

Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31570. [Epub ahead of print]

PMID:
29707771
4.

Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.

Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ.

J Natl Cancer Inst. 2018 Jan 5. doi: 10.1093/jnci/djx273. [Epub ahead of print]

PMID:
29315431
5.

False increase of glycated hemoglobin due to aspirin interference in Tosoh G8 analyzer.

Gils C, Reinholdt B, Andreassen BD, Brandslund I, Vinholt PJ.

Clin Chem Lab Med. 2018 Apr 25;56(5):e118-e120. doi: 10.1515/cclm-2017-0768. No abstract available.

PMID:
29306911
6.

Influence of breast compression pressure on the performance of population-based mammography screening.

Holland K, Sechopoulos I, Mann RM, den Heeten GJ, van Gils CH, Karssemeijer N.

Breast Cancer Res. 2017 Nov 28;19(1):126. doi: 10.1186/s13058-017-0917-3.

7.

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.

Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee IM, Kaaks R, Campa D.

Int J Cancer. 2018 Mar 15;142(6):1182-1188. doi: 10.1002/ijc.31145. Epub 2017 Nov 17.

PMID:
29114882
8.

The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial.

Gal R, Monninkhof EM, Groenwold RHH, van Gils CH, van den Bongard DHJG, Peeters PHM, Verkooijen HM, May AM.

Trials. 2017 Oct 27;18(1):504. doi: 10.1186/s13063-017-2252-5.

9.

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.

Vreemann S, Gubern-Mérida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM.

Radiology. 2018 Feb;286(2):443-451. doi: 10.1148/radiol.2017170458. Epub 2017 Oct 16.

PMID:
29040037
10.

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.

Gray E, Donten A, Karssemeijer N, van Gils C, Evans DG, Astley S, Payne K.

Value Health. 2017 Sep;20(8):1100-1109. doi: 10.1016/j.jval.2017.04.012. Epub 2017 Jun 1.

PMID:
28964442
11.

A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.

Chajès V, Assi N, Biessy C, Ferrari P, Rinaldi S, Slimani N, Lenoir GM, Baglietto L, His M, Boutron-Ruault MC, Trichopoulou A, Lagiou P, Katsoulis M, Kaaks R, Kühn T, Panico S, Pala V, Masala G, Bueno-de-Mesquita HB, Peeters PH, van Gils C, Hjartåker A, Standahl Olsen K, Borgund Barnung R, Barricarte A, Redondo-Sanchez D, Menéndez V, Amiano P, Wennberg M, Key T, Khaw KT, Merritt MA, Riboli E, Gunter MJ, Romieu I.

Ann Oncol. 2017 Nov 1;28(11):2836-2842. doi: 10.1093/annonc/mdx482.

PMID:
28950350
12.

Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.

Gregorowitsch ML, van den Bongard HJGD, Young-Afat DA, Pignol JP, van Gils CH, May AM, Verkooijen HM.

Breast Cancer Res Treat. 2018 Jan;167(1):205-213. doi: 10.1007/s10549-017-4495-y. Epub 2017 Sep 11.

PMID:
28894982
13.

Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.

Sarink D, Schock H, Johnson T, Overvad K, Holm M, Tjønneland A, Boutron-Ruault MC, His M, Kvaskoff M, Boeing H, Lagiou P, Papatesta EM, Trichopoulou A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HBA, van Gils CH, Peeters PH, Weiderpass E, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Amiano P, Khaw KT, Travis R, Dossus L, Gunter M, Rinaldi S, Merritt M, Riboli E, Kaaks R, Fortner RT.

Cancer Prev Res (Phila). 2017 Sep;10(9):525-534. doi: 10.1158/1940-6207.CAPR-17-0125. Epub 2017 Jul 12.

14.

Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.

Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, López-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schüz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V.

PLoS Med. 2017 Jun 30;14(6):e1002335. doi: 10.1371/journal.pmed.1002335. eCollection 2017 Jun.

15.

The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.

Wanders JOP, Holland K, Karssemeijer N, Peeters PHM, Veldhuis WB, Mann RM, van Gils CH.

Breast Cancer Res. 2017 Jun 5;19(1):67. doi: 10.1186/s13058-017-0859-9.

16.

The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.

Kuijer A, Verloop J, Visser O, Sonke G, Jager A, van Gils CH, van Dalen T, Elias SG.

Ann Oncol. 2017 Aug 1;28(8):1970-1978. doi: 10.1093/annonc/mdx204.

PMID:
28459994
17.

The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results.

Young-Afat DA, van Gils CH, van den Bongard HJGD, Verkooijen HM; UMBRELLA Study Group.

Breast Cancer Res Treat. 2017 Jul;164(2):445-450. doi: 10.1007/s10549-017-4242-4. Epub 2017 Apr 25.

18.

Patients' and Health Care Providers' Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation.

Young-Afat DA, van Gils CH, Bruinvels DJ, van der Pol CC, Witkamp AJ, Sijtsema S, Jonasse Y, Bijlsma RM, Ausems MG, Bos AM, van den Bongard DH, Verkooijen HM.

JMIR Cancer. 2016 Jun 7;2(1):e8. doi: 10.2196/cancer.5334.

19.

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.

Charaghvandi RK, van Asselen B, Philippens ME, Verkooijen HM, van Gils CH, van Diest PJ, Pijnappel RM, Hobbelink MG, Witkamp AJ, van Dalen T, van der Wall E, van Heijst TC, Koelemij R, van Vulpen M, van den Bongard HJ.

BMC Cancer. 2017 Mar 9;17(1):181. doi: 10.1186/s12885-017-3144-5.

20.

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.

Fortner RT, Sarink D, Schock H, Johnson T, Tjønneland A, Olsen A, Overvad K, Affret A, His M, Boutron-Ruault MC, Boeing H, Trichopoulou A, Naska A, Orfanos P, Palli D, Sieri S, Mattiello A, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Peeters PH, Van Gils CH, Weiderpass E, Lund E, Quirós JR, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Key T, Khaw KT, Rinaldi S, Dossus L, Gunter M, Merritt MA, Riboli E, Kaaks R.

BMC Med. 2017 Feb 8;15(1):26. doi: 10.1186/s12916-017-0786-8.

21.

Quantification of masking risk in screening mammography with volumetric breast density maps.

Holland K, van Gils CH, Mann RM, Karssemeijer N.

Breast Cancer Res Treat. 2017 Apr;162(3):541-548. doi: 10.1007/s10549-017-4137-4. Epub 2017 Feb 4.

22.

Volumetric breast density affects performance of digital screening mammography.

Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N.

Breast Cancer Res Treat. 2017 Feb;162(1):95-103. doi: 10.1007/s10549-016-4090-7. Epub 2016 Dec 23.

23.

Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.

Burton A, Byrnes G, Stone J, Tamimi RM, Heine J, Vachon C, Ozmen V, Pereira A, Garmendia ML, Scott C, Hipwell JH, Dickens C, Schüz J, Aribal ME, Bertrand K, Kwong A, Giles GG, Hopper J, Pérez Gómez B, Pollán M, Teo SH, Mariapun S, Taib NA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Flugelman AA, Ursin G, Qureshi S, Ma H, Lee E, Sirous R, Sirous M, Lee JW, Kim J, Salem D, Kamal R, Hartman M, Miao H, Chia KS, Nagata C, Vinayak S, Ndumia R, van Gils CH, Wanders JO, Peplonska B, Bukowska A, Allen S, Vinnicombe S, Moss S, Chiarelli AM, Linton L, Maskarinec G, Yaffe MJ, Boyd NF, Dos-Santos-Silva I, McCormack VA.

Breast Cancer Res. 2016 Dec 19;18(1):130.

24.

Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.

Matejcic M, de Batlle J, Ricci C, Biessy C, Perrier F, Huybrechts I, Weiderpass E, Boutron-Ruault MC, Cadeau C, His M, Cox DG, Boeing H, Fortner RT, Kaaks R, Lagiou P, Trichopoulou A, Benetou V, Tumino R, Panico S, Sieri S, Palli D, Ricceri F, Bueno-de-Mesquita HB, Skeie G, Amiano P, Sánchez MJ, Chirlaque MD, Barricarte A, Quirós JR, Buckland G, van Gils CH, Peeters PH, Key TJ, Riboli E, Gylling B, Zeleniuch-Jacquotte A, Gunter MJ, Romieu I, Chajès V.

Int J Cancer. 2017 Mar 15;140(6):1246-1259. doi: 10.1002/ijc.30536.

25.

Congenital Chloride Diarrhea: Diagnosis by Easy-Accessible Chloride Measurement in Feces.

Gils C, Eckhardt MC, Nielsen PE, Nybo M.

Case Rep Pediatr. 2016;2016:2519498. doi: 10.1155/2016/2519498. Epub 2016 Aug 22.

26.

Fiber intake modulates the association of alcohol intake with breast cancer.

Romieu I, Ferrari P, Chajès V, de Batlle J, Biessy C, Scoccianti C, Dossus L, Christine Boutron M, Bastide N, Overvad K, Olsen A, Tjønneland A, Kaaks R, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Gils CH, Peeters PH, Lund E, Skeie G, Weiderpass E, Ramón Quirós J, Chirlaque MD, Ardanaz E, Sánchez MJ, Duell EJ, Amiano Etxezarreta P, Borgquist S, Hallmans G, Johansson I, Maria Nilsson L, Khaw KT, Wareham N, Key TJ, Travis RC, Murphy N, Wark PA, Riboli E.

Int J Cancer. 2017 Jan 15;140(2):316-321. doi: 10.1002/ijc.30415.

27.

Pre-adult famine exposure and subsequent colorectal cancer risk in women.

Brand MP, Peeters PH, van Gils CH, Elias SG.

Int J Epidemiol. 2017 Apr 1;46(2):612-621. doi: 10.1093/ije/dyw121.

28.

Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

Gils C, Pottegård A, Ennis ZN, Damkier P.

BMC Pregnancy Childbirth. 2016 Aug 17;16:226. doi: 10.1186/s12884-016-1025-6.

29.

Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.

Verschoor AM, Kuijer A, Verloop J, Van Gils CH, Sonke GS, Jager A, van Dalen T, Elias SG.

Breast Cancer Res Treat. 2016 Sep;159(2):357-65. doi: 10.1007/s10549-016-3940-7. Epub 2016 Aug 12.

PMID:
27514397
30.

Consistency of breast density categories in serial screening mammograms: A comparison between automated and human assessment.

Holland K, van Zelst J, den Heeten GJ, Imhof-Tas M, Mann RM, van Gils CH, Karssemeijer N.

Breast. 2016 Oct;29:49-54. doi: 10.1016/j.breast.2016.06.020. Epub 2016 Jul 13.

PMID:
27420382
31.

Impact of reconstruction parameters on quantitative I-131 SPECT.

van Gils CA, Beijst C, van Rooij R, de Jong HW.

Phys Med Biol. 2016 Jul 21;61(14):5166-82. doi: 10.1088/0031-9155/61/14/5166. Epub 2016 Jun 28.

PMID:
27352225
32.

The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?

van der Velden JM, Verkooijen HM, Young-Afat DA, Burbach JP, van Vulpen M, Relton C, van Gils CH, May AM, Groenwold RH.

Int J Epidemiol. 2017 Feb 1;46(1):96-102. doi: 10.1093/ije/dyw050.

PMID:
27118559
33.

Thrombophilia prevalence among women with placenta-mediated pregnancy complications.

Gils C, Nybo M.

Int J Gynaecol Obstet. 2016 Aug;134(2):156-9. doi: 10.1016/j.ijgo.2015.12.007. Epub 2016 Apr 8.

PMID:
27113416
34.

Brief Report: Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design.

Young-Afat DA, Verkooijen HA, van Gils CH, van der Velden JM, Burbach JP, Elias SG, van Delden JJ, Relton C, van Vulpen M, van der Graaf R.

Epidemiology. 2016 May;27(3):389-92. doi: 10.1097/EDE.0000000000000435. Erratum in: Epidemiology. 2016 Jul;27(4):e31.

PMID:
27035689
35.
36.

Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Bakker MF, Peeters PH, Klaasen VM, Bueno-de-Mesquita HB, Jansen EH, Ros MM, Travier N, Olsen A, Tjønneland A, Overvad K, Rinaldi S, Romieu I, Brennan P, Boutron-Ruault MC, Perquier F, Cadeau C, Boeing H, Aleksandrova K, Kaaks R, Kühn T, Trichopoulou A, Lagiou P, Trichopoulos D, Vineis P, Krogh V, Panico S, Masala G, Tumino R, Weiderpass E, Skeie G, Lund E, Quirós JR, Ardanaz E, Navarro C, Amiano P, Sánchez MJ, Buckland G, Ericson U, Sonestedt E, Johansson M, Sund M, Travis RC, Key TJ, Khaw KT, Wareham N, Riboli E, van Gils CH.

Am J Clin Nutr. 2016 Feb;103(2):454-64. doi: 10.3945/ajcn.114.101659. Epub 2016 Jan 20.

PMID:
26791185
37.

International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.

McCormack VA, Burton A, dos-Santos-Silva I, Hipwell JH, Dickens C, Salem D, Kamal R, Hartman M, Lee CP, Chia KS, Ozmen V, Aribal ME, Flugelman AA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Ursin G, Qureshi S, Ma H, Lee E, van Gils CH, Wanders JO, Vinayak S, Ndumia R, Allen S, Vinnicombe S, Moss S, Won Lee J, Kim J, Pereira A, Garmendia ML, Sirous R, Sirous M, Peplonska B, Bukowska A, Tamimi RM, Bertrand K, Nagata C, Kwong A, Vachon C, Scott C, Perez-Gomez B, Pollan M, Maskarinec G, Giles G, Hopper J, Stone J, Rajaram N, Teo SH, Mariapun S, Yaffe MJ, Schüz J, Chiarelli AM, Linton L, Boyd NF.

Cancer Epidemiol. 2016 Feb;40:141-51. doi: 10.1016/j.canep.2015.11.015. Epub 2015 Dec 24.

38.

Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort.

Emaus MJ, Peeters PH, Bakker MF, Overvad K, Tjønneland A, Olsen A, Romieu I, Ferrari P, Dossus L, Boutron-Ruault MC, Baglietto L, Fortner RT, Kaaks R, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Pala V, Panico S, Tumino R, Polidoro S, Skeie G, Lund E, Weiderpass E, Quirós JR, Travier N, Sánchez MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Winkvist A, Wennberg M, Bueno-de-Mesquita HB, Khaw KT, Travis RC, Key TJ, Aune D, Gunter M, Riboli E, van Gils CH.

Am J Clin Nutr. 2016 Jan;103(1):168-77. doi: 10.3945/ajcn.114.101436. Epub 2015 Nov 25.

PMID:
26607934
39.

Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Kyrø C, Zamora-Ros R, Scalbert A, Tjønneland A, Dossus L, Johansen C, Bidstrup PE, Weiderpass E, Christensen J, Ward H, Aune D, Riboli E, His M, Clavel-Chapelon F, Baglietto L, Katzke V, Kühn T, Boeing H, Floegel A, Overvad K, Lasheras C, Travier N, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Khaw KT, Wareham N, Perez-Cornago A, Trichopoulou A, Lagiou P, Vasilopoulou E, Masala G, Grioni S, Berrino F, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, van Gils C, Borgquist S, Butt S, Zeleniuch-Jacquotte A, Sund M, Hjartåker A, Skeie G, Olsen A, Romieu I.

Breast Cancer Res Treat. 2015 Nov;154(2):389-401. doi: 10.1007/s10549-015-3595-9. Epub 2015 Nov 3.

PMID:
26531755
40.

A Population-Based Study of Cholesterol Measurements in the Oldest Old.

Gils C, Christensen K, Nybo M.

Curr Aging Sci. 2015;8(3):282-7.

PMID:
26329161
41.

NT-proBNP on Cobas h 232 in point-of-care testing: Performance in the primary health care versus in the hospital laboratory.

Gils C, Ramanathan R, Breindahl T, Brokner M, Christiansen AL, Eng Ø, Hammer IJ, Herrera CB, Jansen A, Langsjøen EC, Løkkebo ES, Osestad T, Schrøder AD, Walther L.

Scand J Clin Lab Invest. 2015 Nov;75(7):602-9. doi: 10.3109/00365513.2015.1066846. Epub 2015 Aug 11.

PMID:
26305423
42.

Geographic variation in volumetric breast density between screening regions in the Netherlands.

van der Waal D, Emaus MJ, Bakker MF, den Heeten GJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, Verbeek AL, van Gils CH, Broeders MJ.

Eur Radiol. 2015 Nov;25(11):3328-37. doi: 10.1007/s00330-015-3742-z. Epub 2015 Jul 3.

43.

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.

Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, Bisschops RH, Veltman J, Duvivier KM, Lobbes MB, Pijnappel RM, Karssemeijer N, de Koning HJ, van den Bosch MA, Monninkhof EM, Mali WP, Veldhuis WB, van Gils CH.

Radiology. 2015 Nov;277(2):527-37. doi: 10.1148/radiol.2015141827. Epub 2015 Jun 23.

PMID:
26110667
44.

The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort.

Wanders JO, Bakker MF, Veldhuis WB, Peeters PH, van Gils CH.

Breast Cancer Res. 2015 May 30;17:74. doi: 10.1186/s13058-015-0583-2.

45.

Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.

Romaguera D, Ward H, Wark PA, Vergnaud AC, Peeters PH, van Gils CH, Ferrari P, Fedirko V, Jenab M, Boutron-Ruault MC, Dossus L, Dartois L, Hansen CP, Dahm CC, Buckland G, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Key TJ, Trichopoulou A, Tsironis C, Lagiou P, Masala G, Pala V, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Ohlsson B, Jirström K, Wennberg M, Nilsson LM, Weiderpass E, Kühn T, Katzke V, Khaw KT, Wareham NJ, Tjønneland A, Boeing H, Quirós JR, Gunter MJ, Riboli E, Norat T.

BMC Med. 2015 May 7;13:107. doi: 10.1186/s12916-015-0332-5.

46.

Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition.

Romieu I, Scoccianti C, Chajès V, de Batlle J, Biessy C, Dossus L, Baglietto L, Clavel-Chapelon F, Overvad K, Olsen A, Tjønneland A, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Lund E, Skeie G, Weiderpass E, Quirós García JR, Chirlaque MD, Ardanaz E, Sánchez MJ, Duell EJ, Amiano P, Borgquist S, Wirfält E, Hallmans G, Johansson I, Nilsson LM, Khaw KT, Wareham N, Key TJ, Travis RC, Murphy N, Wark PA, Ferrari P, Riboli E.

Int J Cancer. 2015 Oct 15;137(8):1921-30. doi: 10.1002/ijc.29469. Epub 2015 Jul 14.

47.

Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.

Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, Overvad K, Tjønneland A, Olsen A, Clavel-Chapelon F, Fagherazzi G, Perquier F, Teucher B, Kaaks R, Schütze M, Boeing H, Lagiou P, Orfanos P, Trichopoulou A, Agnoli C, Mattiello A, Palli D, Tumino R, Sacerdote C, van Duijnhoven FJ, Braaten T, Lund E, Skeie G, Redondo ML, Buckland G, Pérez MJ, Chirlaque MD, Ardanaz E, Amiano P, Wirfält E, Wallström P, Johansson I, Nilsson LM, Khaw KT, Wareham N, Allen NE, Key TJ, Rinaldi S, Romieu I, Gallo V, Riboli E, van Gils CH.

Breast Cancer Res. 2015 Jan 31;17:15. doi: 10.1186/s13058-015-0521-3.

48.

Evaluation of patient registries supporting reimbursement decisions: the case of oxaliplatin for treatment of stage III colon cancer.

Mohseninejad L, van Gils C, Uyl-de Groot CA, Buskens E, Feenstra T.

Value Health. 2015 Jan;18(1):84-90. doi: 10.1016/j.jval.2014.10.008.

49.

SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study.

Pottegård A, Haastrup MB, Stage TB, Hansen MR, Larsen KS, Meegaard PM, Meegaard LH, Horneberg H, Gils C, Dideriksen D, Aagaard L, Almarsdottir AB, Hallas J, Damkier P.

BMJ. 2014 Dec 16;349:g7092. doi: 10.1136/bmj.g7092. Review.

50.

Noncollapsibility and censoring: what's the bias in estimating effects on survival?

Goossens L, Redekop K, van Gils C.

Epidemiology. 2015 Jan;26(1):e1-2. doi: 10.1097/EDE.0000000000000197. No abstract available.

PMID:
25437319

Supplemental Content

Support Center